1 active not recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Lumen Bioscience, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LMN-201 for Prevention of C. Difficile Infection Recurrence LMN-201, Placebo - Clostridioides Difficile Infection | Phase 2 / Phase 3 | Active not recruiting | Lumen Bioscience, Inc. | 375 | 2024-08-29 | 2026-10-05 |
United States (1)